Cargando…
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19
The severe respiratory insufficiency observed during COVID-19 infection may not be directly related to a cytopathogenic effect induced by the virus itself, but to an exaggerated and inappropriate immune response. In an effort to reduce the severity of organ dysfunction, including respiratory insuffi...
Autores principales: | Meletiadis, Joseph, Tsiodras, Sotirios, Tsirigotis, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680461/ https://www.ncbi.nlm.nih.gov/pubmed/32789663 http://dx.doi.org/10.1007/s40121-020-00326-1 |
Ejemplares similares
-
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis()()
por: Jung, In Hye, et al.
Publicado: (2015) -
Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
por: Lokau, Juliane, et al.
Publicado: (2019) -
Circulating miRNAs as new activators of the JAK-STAT3 pathway
por: Lam, David, et al.
Publicado: (2013) -
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
por: Di Benedetto, Paola, et al.
Publicado: (2021) -
Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells
por: Russell, Mark A., et al.
Publicado: (2013)